XML 50 R39.htm IDEA: XBRL DOCUMENT
v3.25.1

Commitments and Contingencies (Details) - USD ($) $ in Thousands |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | ---
Sep. 30, 2023 | Mar. 31, 2025 | Dec. 31, 2023 | Dec. 30, 2022
Mayne Pharma Agreement [Member] |  |  |  |
Commitments and Contingencies [Line Items] |  |  |  |
Acquisition of net working capital |  |  |  | $ 12,100
Adjustment of increase in accrual on working capital | $ 2,000 |  |  |
Working capital amounts |  |  | $ 5,500 |
Maximum [Member] |  |  |  |
Commitments and Contingencies [Line Items] |  |  |  |
Increased allowance for net working capital |  |  | 5,500 |
Minimum [Member] |  |  |  |
Commitments and Contingencies [Line Items] |  |  |  |
Increased allowance for net working capital |  |  | $ 2,000 |
Paragraph IV Certification Notice Letter [Member] |  |  |  |
Commitments and Contingencies [Line Items] |  |  |  |
Legal costs |  | $ 2,334 |  |

X
- Definition Amount of adjustment of the increase in accruals on working capital. + References No definition available. + Details
Name: | txmd_AdjustmentOfIncreaseInAccrualOnWorkingCapital
Namespace Prefix: | txmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received for net working capital. + References No definition available. + Details
Name: | txmd_CashReceivedForNetWorkingCapital
Namespace Prefix: | txmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increased allowance for net working capital. + References No definition available. + Details
Name: | txmd_IncreasedAllowanceForNetWorkingCapital
Namespace Prefix: | txmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Working capital amounts. + References No definition available. + Details
Name: | txmd_WorkingCapitalAmounts
Namespace Prefix: | txmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (k) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(6)) -SubTopic 10 -Topic 220 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_LegalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_OtherCommitmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=txmd_MaynePharmaAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | txmd_LegalProceedingAxis=txmd_ParagraphFourCertificationNoticeLetterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |